We are developing a potential break-through COVID-19 immunisation. Learn More

Introduction

Coronavirus disease (COVID-19) is an infectious disease caused by a newly discovered coronavirus in 2019.

Coronavirus.

It's estimated that 4.5 billion people globally have been impacted by COVID-19 to date.

225,400,000

Total stated cases of COVID-19 (Coronavirus) globally

4,650,000

Total stated deaths from COVID-19 (Coronavirus) globally

218

Total stated countries where COVID-19 (Coronavirus) is present.

Data accurate as of 14th September 2020.
Data sourced from Johns Hopkins University (JHU)

The Numbers

Here are milestones and stats regarding the Coronavirus globally.

225.4m

There are over 225 million stated cases of Coronavirus globally.

4.5b

It's estimated that the coronavirus has impacted over 4.5 billion people.

1t

Estimated coronavirus cost to the global economy is over $1 trillion dollars.

Disclaimer

The Immubio platform and ImmubioCV are currently in the early-stage development phase. The Immubio platform and any produced immunisations are being developed for government direct sales and as such we will not sell directly to consumers. Our Immubio range of immunisations are yet to be tested for safety and effectiveness. Studies are planned to confirm safety and effectiveness. Any claims made on this site or in Open Care documents have not been reviewed or evaluated by any international or local health regulators including but not limited to the FDA, HC, EMA or TGA. Until the Immubio platform and ImmubioCV products are registered with the relevant health regulators, all Immubio products that we develop will not be available for use or supply except for use in clinical trials. If you have a serious health concern, please follow official government and medical guidelines and seek professional medical advice.